Grant: Operating Grant
Sunnybrook Research Institute (Toronto, Ontario)
$598,622.00
Design and in vivo delivery of novel anti-inflammatory agents
EF 2012-13
Résumé
Inflammation is a term that describes how our body's immune system reacts to damaged tissues, infections or the presence of agents that cause irritations such as allergens. If the tissue or organ involved is progressively damaged or if an infection or irritant persist, the resulting inflammatory responses become chronic leading to a range of immune response-related diseases, exemplified by medical conditions such as hay fever, atherosclerosis, Crohn's disease and rheumatoid arthritis. In this proposal, we plan to generate synthetic, targeted biomolecules that will specifically block or dampen uncontrolled immune responses.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
267940
Name
Gariepy Jean
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Pharmaceutical Sciences
Projecttitle
Design and in vivo delivery of novel anti-inflammatory agents
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$598,622
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Aptamers; Cd200; Cd200r1; Immune Monitoring; Inflammation; Mouse Models; Peptides; Tnf Alpha
Abstract
Inflammation is a term that describes how our body's immune system reacts to damaged tissues, infections or the presence of agents that cause irritations such as allergens. If the tissue or organ involved is progressively damaged or if an infection or irritant persist, the resulting inflammatory responses become chronic leading to a range of immune response-related diseases, exemplified by medical conditions such as hay fever, atherosclerosis, Crohn's disease and rheumatoid arthritis. In this proposal, we plan to generate synthetic, targeted biomolecules that will specifically block or dampen uncontrolled immune responses.
Competitiondate
201209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gariepy, Jean
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $598,622~ $0~